Related Experiment Video
Updated: Jun 7, 2025

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
EMCV VP2 degrades IFI16 through Caspase-dependent apoptosis to evade IFI16-STING pathway
Ruofei Feng1,2, Dianyu Li1,3, Zhenfang Yan1,3
1Key Laboratory of Biotechnology and Bioengineering of State Ethnic Biomedical Research Center, Northwest Minzu University, Lanzhou, China.
Abstract:
Interferon (IFN)-γ inducible protein 16 (IFI16), a key DNA sensor, triggers downstream STING-dependent type I interferon (IFN-I) production and antiviral immunity. However, how the IFI16-STING signaling pathway is regulated by EMCV infection is still not well elucidated. In this study, we investigated the interaction between IFI16 and EMCV. Results indicated EMCV infection suppressed IFI16 expression in A549 cells. This study reveals that IFI16 plays an active role in combating EMCV. Screening viral proteins in conjunction with IFI16, we found that the EMCV VP2 protein hinders the antiviral response mediated by IFI16 by causing degradation of the IFI16 protein via the caspase-dependent apoptosis pathway. Our study communicates the antiviral role of the IFI16-STING pathway during EMCV infection. Importantly, this study unveils the novel mechanism by which VP2 counteracts the innate immune signaling activated by foreign DNA.
Insights
Interferon-gamma inducible protein 16 (IFI16) fights EMCV infection. However, EMCV VP2 protein degrades IFI16, suppressing antiviral immunity via apoptosis.
Area of Science:
- Innate immunity
- Molecular virology
- Cellular signaling
Background:
- Interferon-gamma inducible protein 16 (IFI16) is a DNA sensor crucial for initiating antiviral responses through the STING-dependent type I interferon (IFN-I) pathway.
- The precise regulation of the IFI16-STING signaling pathway during Enterovirus species C (EMCV) infection remains incompletely understood.
Purpose of the Study:
- To investigate the interaction between IFI16 and EMCV.
- To elucidate the mechanism by which EMCV modulates the IFI16-STING antiviral pathway.
Main Methods:
- Investigated IFI16 expression in EMCV-infected A549 cells.
- Screened EMCV viral proteins for interaction with IFI16.
- Analyzed the role of the caspase-dependent apoptosis pathway in IFI16 degradation.
Main Results:
- EMCV infection was found to suppress IFI16 expression in A549 cells.
- The EMCV VP2 protein was identified as a factor that hinders the IFI16-mediated antiviral response.
- VP2 induces degradation of IFI16 through a caspase-dependent apoptosis pathway.
Conclusions:
- IFI16 plays an active role in combating EMCV infection.
- The EMCV VP2 protein employs a novel mechanism to counteract IFI16-STING innate immune signaling by promoting IFI16 degradation.
- Understanding this interaction is key to developing strategies against EMCV infections.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...

